PT  - JOURNAL ARTICLE
AU  - Sylvan, S Eketorp
AU  - Lundin, J
AU  - Ipek, M
AU  - Palma, M
AU  - Karlsson, C
AU  - Hansson, L
TI  - P27. Alemtuzumab (anti-CD52 monoclonal antibody) as single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL) – a single region experience on consecutive patients
AID  - 10.1186/2051-1426-2-S2-P18
DP  - 2014 Mar 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - P18
VI  - 2
IP  - Suppl 2
4099  - http://jitc.bmj.com/content/2/Suppl_2/P18.short
4100  - http://jitc.bmj.com/content/2/Suppl_2/P18.full
SO  - J Immunother Cancer2014 Mar 01; 2